NNVC (STOCKS)
NanoViricides Inc.
$1.401100
+0.181100 (+14.84%)
Prev close: $1.220000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Anil R. Diwan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $32.29M
- Employees
- 7
- P/E (TTM)
- -3.24
- P/B (TTM)
- 2.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.11 | $-0.14 | +0.0328 | +22.97% |
|
Sep 2025 (Q1)
|
$-0.10 | $-0.18 | +0.0836 | +45.53% |
|
Mar 2024 (Q4)
|
$-0.19 | $-0.20 | +0.0140 | +6.86% |
|
Mar 2024 (Q3)
|
$-0.16 | $-0.19 | +0.0338 | +17.44% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $84.69K |
| Operating Expenses | $8.18M |
| Research and Development | $4.58M |
| Other Operating Expenses | $3.60M |
| Operating Income/Loss | -$8.18M |
| Income/Loss From Continuing Operations After Tax | -$8.09M |
| Income/Loss From Continuing Operations Before Tax | -$8.09M |
| Net Income/Loss | -$8.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 58,896,645 |
| Diluted Average Shares | 58,896,645 |
| Assets | $10.22M |
| Current Assets | $3.38M |
| Prepaid Expenses | $164.66K |
| Other Current Assets | $3.21M |
| Noncurrent Assets | $6.84M |
| Fixed Assets | $6.53M |
| Intangible Assets | $310.84K |
| Other Non-current Assets | $1.38K |
| Liabilities | $1.10M |
| Current Liabilities | $1.07M |
| Wages | $25.85K |
| Other Current Liabilities | $1.04M |
| Noncurrent Liabilities | $34.59K |
| Equity | $9.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.15M |
| Liabilities And Equity | $10.22M |
| Net Cash Flow From Operating Activities | -$7.28M |
| Net Cash Flow From Operating Activities, Continuing | -$7.28M |
| Net Cash Flow From Investing Activities | -$94.52K |
| Net Cash Flow From Investing Activities, Continuing | -$94.52K |
| Net Cash Flow From Financing Activities | $8.04M |
| Net Cash Flow From Financing Activities, Continuing | $8.04M |
| Net Cash Flow | $670.67K |
| Net Cash Flow, Continuing | $670.67K |
| Comprehensive Income/Loss | -$8.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.09M |
| Other Comprehensive Income/Loss | $0.00 |